Table 4.
Characterization for stents encrustation Bladder (N = 99) and Renal (N = 99) ends
| Percentage (%) of encrustation in stents | ||||||||
|---|---|---|---|---|---|---|---|---|
| Bladder end | Renal end | |||||||
| 0 | 1 | 2 | 3 | 0 | 1 | 2 | 3 | |
| no deposit | 28.3 | 41.4 | ||||||
| OM | 12.1 | 8.1 | ||||||
| COM | 24.2 | 27.3 | ||||||
| COM + COD | 14.1 | 11.1 | ||||||
| BRU | 2.0 | 1.0 | 2.0 | |||||
| HAP | 1.0 | 1.1 | 1.0 | |||||
| HAP + BRU | 1.0 | 3.0 | 3.0 | |||||
| UA | 3.0 | 2.0 | ||||||
| UA + COM | 1.0 | 1.0 | ||||||
| bacteria | 4.0 | 2.0 | ||||||
| HAP + PAM | 2.0 | 1.0 | ||||||
| BRU + COD | 1.0 | – | – | – | – | |||
| AU | 1.0 | – | – | – | – | |||
OM organic matter; COM calcium oxalate monohydrate; COD calcium oxalate dihydrate; BRU brushite; HAP hydroxyapatite; UA uric acid; PAM ammonium magnesium phosphate; AU ammonium urate